Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
95.311,20
-1,95%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Lucid Diagnostics Inc (LUCD) Lucid Diagnostics Inc (LUCD) Notizie

LUCD

Lucid Diagnostics (LUCD)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:LUCD
DataOraFonteTitoloSimboloCompagnia
20/12/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
19/12/202414:01PR Newswire (US)Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for FirefightersNASDAQ:LUCDLucid Diagnostics Inc
11/12/202414:01PR Newswire (US)Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed PublicationNASDAQ:LUCDLucid Diagnostics Inc
06/12/202422:10Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:LUCDLucid Diagnostics Inc
03/12/202414:01PR Newswire (US)Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term MilestonesNASDAQ:LUCDLucid Diagnostics Inc
20/11/202413:56PR Newswire (US)Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA TestNASDAQ:LUCDLucid Diagnostics Inc
18/11/202414:15PR Newswire (US)Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:LUCDLucid Diagnostics Inc
14/11/202414:01PR Newswire (US)PAVmed Provides Business Update and Third Quarter 2024 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
13/11/202414:01PR Newswire (US)Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
12/11/202422:36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LUCDLucid Diagnostics Inc
07/11/202414:01PR Newswire (US)Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed PublicationNASDAQ:LUCDLucid Diagnostics Inc
05/11/202414:01PR Newswire (US)Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue DriversNASDAQ:LUCDLucid Diagnostics Inc
31/10/202413:31PR Newswire (US)PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024NASDAQ:LUCDLucid Diagnostics Inc
30/10/202413:31PR Newswire (US)Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 13, 2024NASDAQ:LUCDLucid Diagnostics Inc
15/10/202413:51PR Newswire (US)Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA TestNASDAQ:LUCDLucid Diagnostics Inc
09/10/202414:01PR Newswire (US)Lucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual SummitNASDAQ:LUCDLucid Diagnostics Inc
08/10/202413:49PR Newswire (US)Lucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024NASDAQ:LUCDLucid Diagnostics Inc
01/10/202414:01PR Newswire (US)Lucid Diagnostics Holds Inaugural #CheckYourFoodTube Precancer Testing Event for Former NFL PlayersNASDAQ:LUCDLucid Diagnostics Inc
24/09/202414:01PR Newswire (US)American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer TestNASDAQ:LUCDLucid Diagnostics Inc
16/09/202422:30PR Newswire (US)PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing RequirementsNASDAQ:LUCDLucid Diagnostics Inc
10/09/202413:56PR Newswire (US)Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World CongressNASDAQ:LUCDLucid Diagnostics Inc
03/09/202413:51PR Newswire (US)Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile HealthNASDAQ:LUCDLucid Diagnostics Inc
20/08/202414:16PR Newswire (US)Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and CancerNASDAQ:LUCDLucid Diagnostics Inc
13/08/202414:16PR Newswire (US)The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal CancerNASDAQ:LUCDLucid Diagnostics Inc
13/08/202414:01PR Newswire (US)PAVmed Provides Business Update and Second Quarter 2024 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
12/08/202414:07PR Newswire (US)Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
08/08/202414:31PR Newswire (US)Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing EventNASDAQ:LUCDLucid Diagnostics Inc
06/08/202414:15PR Newswire (US)Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer TestingNASDAQ:LUCDLucid Diagnostics Inc
05/08/202414:15PR Newswire (US)Lucid Diagnostics to Participate in Upcoming Investor ConferencesNASDAQ:LUCDLucid Diagnostics Inc
30/07/202414:15PR Newswire (US)PAVmed to Hold a Business Update Conference Call and Webcast on August 13, 2024NASDAQ:LUCDLucid Diagnostics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:LUCD

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
STLAM
Stellantis NV
BIT
SPM
Saipem
BIT
ENEL
Enel
BIT
TIT
Telecom Italia
BIT
RACE
Ferrari NV
BIT
STMMI
ST Microelectronics
BIT
BAMI
Banco BPM
BIT
BPE
Bper Banca
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
PRY
Prysmian
BIT
TEN
Tenaris
BIT
MONC
Moncler
BIT
FBK
Finecobank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network